Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

Globalization and Health

Research

María Rubín-García¹  Vicente Martín-Sánchez¹  Laura Álvarez-Álvarez¹  Jordi Salas-Salvadó²  Sara de las Heras-Delgado²  Nadine Khoury²  Cristina Valle-Hita²  Carmen Sayón-Orea³  J. Alfredo Martínez⁴  Emilio Ros⁵  Francisco J. Tinahones⁶  José C. Fernández-García⁶  José Lapetra⁷  José Manuel Santos-Lozano⁷  Ramon Estruch⁸  Sara Castro-Barquero⁸  Julia Wärnberg⁹  Itziar Abete^1,10  María Ángeles Zulet^1,10  Miguel Ángel Martínez-González^1,11  Maira Bes-Rastrollo^1,11  Patricia Guillem-Saiz^1,12  Dolores Corella^1,12  Rocío Barragán^1,12  Enrique Gómez-Gracia^1,13  Antoni Colom^1,14  Dora Romaguera^1,14  Lluís Serra-Majem^1,15  José Lopez-Miranda^1,16  Antonio García-Ríos^1,16  Xavier Pintó^1,17  Juan Carlos Cenoz^1,18  Ángel M. Alonso-Gómez^1,19  Jessica Vaquero-Luna^1,19  Leire Goicolea-Güemez^1,19  Josep A. Tur^2,20  Cristina Bouzas^2,20  Silvia García^2,20  Margalida Monserrat-Mesquida^2,20  Olga Castañer^2,21  Ramon Ciurana^2,21  Robert Cabanes^2,21  Albert Goday^2,22  Pilar Matía^2,23  Clotilde Vázquez^2,24  Josep Vidal^2,25  José J. Gaforio^2,26  Blanca Riquelme-Gallego^2,27  Jesús Vioque^2,28  Cristina Tercero-Maciá^2,29  Lidia Daimiel^3,30  Rosario Pastor^3,31 

[1] CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Institute of Biomedicine (IBIOMED), University of León, 24071, Leon, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Biochemistry and Biotechnology Department. Human Nutrition Unit, Universitat Rovira i Virgili, IISPV, Hospital Universitari de Sant Joan, 43201, Reus, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Navarra Institute of Public Health. Regional Health Service of Navarra, Pamplona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Cardiometabolics Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049, Madrid, Spain;Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008, Pamplona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Endocrinology and Nutrition, Lipid Clinic, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036, Barcelona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Endocrinology, Virgen de la Victoria Hospital, University of Málaga, 29010, Málaga, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013, Sevilla, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036, Barcelona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071, Málaga, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008, Pamplona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, 31008, Pamplona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Preventive Medicine, University of Valencia, 46100, Valencia, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Department of Public Health and Psychiatry, School of Medicine, Biomedical Research Institute of Malaga (IBIMA), University of Malaga, 29010, Málaga, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma de Mallorca, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016, Las Palmas, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, 14004, Córdoba, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, 08907, Hospitalet de Llobregat, Barcelona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Navarra Regional Health Service, Primary Health Care Services, Pamplona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Osakidetza Basque Health Service, Bioaraba Health Research Institute, Araba University Hospital, University of the Basque Country UPV/EHU, 48013, Vitoria-Gasteiz, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain;Health Research Institute of the Balearic Islands (IdISBa), 07120, Palma de Mallorca, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003, Barcelona, Spain;CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain;Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003, Barcelona, Spain;Departament of Medicine, Universitat Autònoma de Barcelona, 08003, Barcelona, Spain;Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040, Madrid, Spain;Department of Endocrinology, Fundación Jiménez-Díaz, 28040, Madrid, Spain;Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, 08036, Barcelona, Spain;Faculty of Health Sciences, Catholic University of Avila, 05005, Avila, Spain;Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, 23071, Jaen, Spain;Faculty of Health Sciences, Catholic University of Avila, 05005, Avila, Spain;Department of Preventive Medicine, University of Granada, 18071, Granada, Spain;Faculty of Health Sciences, Catholic University of Avila, 05005, Avila, Spain;Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03550, Alicante, Spain;Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernández (ISABIAL-UMH), 03550, Alicante, Spain;Centro Salud Raval, 03203, Elche-Alicante, Spain;Precision Nutrition and Obesity Program.IMDEA Food, Nutritional Control of the Epigenome Group, CEI UAM + CSIC, 28049, Madrid, Spain;Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands & CIBEROBN, Guillem Colom Bldg, Campus, E-07122, Palma de Mallorca, Spain;Faculty of Health Sciences, Catholic University of Avila, 05005, Avila, Spain;

关键词: Metabolic syndrome;    Environment;    CO emissions;    Non-communicable diseases;    Glycaemia;    Diet;   

DOI  :  10.1186/s12992-023-00948-3

 received in 2023-01-09, accepted in 2023-06-27,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundMetabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet.AimsTo assess the association between MetS severity and amount of carbon dioxide (CO2) emitted in an adult population.DesignCross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS).MethodsDietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score.ResultsHigher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions.ConclusionsLow CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet.Trial registrationISRCTN, ISRCTN89898870. Registered 05 September 2013.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 2

Fig. 2